Free Trial

Neuberger Berman Group LLC Buys 385,575 Shares of Danaher Corporation (NYSE:DHR)

Danaher logo with Medical background

Key Points

  • Neuberger Berman Group LLC increased its holdings in Danaher Corporation by 13.2% during the first quarter, acquiring an additional 385,575 shares for a total of 3,313,908 shares.
  • As of the most recent quarter, Danaher accounts for approximately 0.6% of Neuberger Berman's portfolio, valued at around $679.64 million.
  • Danaher reported a quarterly earnings per share (EPS) of $1.80, exceeding analyst expectations of $1.64, with revenue of $5.94 billion.
  • Want stock alerts on Danaher? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Neuberger Berman Group LLC lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 13.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,313,908 shares of the conglomerate's stock after purchasing an additional 385,575 shares during the quarter. Danaher accounts for approximately 0.6% of Neuberger Berman Group LLC's holdings, making the stock its 25th largest position. Neuberger Berman Group LLC owned approximately 0.46% of Danaher worth $679,640,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of DHR. GHP Investment Advisors Inc. boosted its position in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter worth about $27,000. Sierra Ocean LLC raised its stake in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC purchased a new stake in shares of Danaher during the 1st quarter worth about $31,000. Finally, Dunhill Financial LLC increased its holdings in shares of Danaher by 68.4% during the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research analyst reports. Leerink Partners upped their price target on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. JPMorgan Chase & Co. decreased their price objective on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Evercore ISI dropped their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Robert W. Baird increased their price objective on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Finally, Royal Bank Of Canada restated an "outperform" rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

View Our Latest Stock Analysis on Danaher

Danaher Price Performance

DHR stock traded up $0.62 during mid-day trading on Friday, hitting $210.84. 3,210,213 shares of the stock were exchanged, compared to its average volume of 4,658,279. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The business has a fifty day moving average price of $199.64 and a 200 day moving average price of $200.12. The stock has a market capitalization of $150.97 billion, a price-to-earnings ratio of 44.86, a PEG ratio of 2.93 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. During the same period in the previous year, the firm posted $1.72 EPS. The business's revenue for the quarter was up 3.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines